I&P Développement I (IPDEV1)


Last updated 11 May 2020, by Impactyield.

Edit this fund

In sub-Saharan Africa, economic activity broadly takes the form of either informal micro-businesses or large multinationals. The difficulty and cost of accessing long-term finance and the lack of strategic consultancy services are the principal brakes on the development of mid-sized businesses. Yet it is precisely these mid-sized businesses which play a key economic role, allowing the development of competitive, job-creating sectors, and providing their employees with secure incomes. IPDEV makes minority equity and quasi-equity investments in mid-sized businesses and microfinance institutions in eleven sub-Saharan African countries and in very diverse sectors (health, agriculture, public works, services, etc).

IPDEV1 supports the transfer of know-how and skills through training missions carried out by teams in the field and through technical assistance. IPDEV also plays the role of an investment catalyst: as a minority shareholder it involves other investors, usually local, in its projects (sometimes helping to identify them).

Financial description

IPDEV1 has made minority equity and quasi equity investments in SMEs and MFIs with a holding period up to 7-8 years.

21 years

of track record


the year funded

11,000,000 EUR


SDG goals

SDG targets

Equal rights to ownership basic services technology and economic resources

Encourage companies to adopt sustainable practices and sustainability reporting

Promote policies to support job creation and growing enterprises

Full employment and decent work with equal pay

Increase access to financial services and markets

Key performance indicators

Fund overview

Asset manager: Investisseurs & Partenaires (I&P)

Product track record: Fund has 21 years of track record

Target IRR: n.a.

Committed Capital: n.a.

Target return category: Below risk-adjusted market-rate of return

Fund domicile:

Product status:

Style/Stage: , , ,

Inception year: 2002

Vintage year: 2003

Target region: , ,

Target close date: n.a.

Product term: n.a.

Assets under management: 11,000,000 EUR (Euro)

Investment size: Min: 50,000; Max: 300,000; Avg: 150,000

Co-investment policy:

Currency of investments:

Currency for fund / product figures:

Fund investments to date: 33

Fund investments to date exited or repaid: 8

Management fee: n.a.

Carried interest: n.a.

Hurdle rate: n.a.

GIIN Investors' Council Investment: No

Limited Partners / Investors: Individuals, Family Office, Corporations and DFIs.

Limited Partner / Investor Type: Development Finance Institution (DFI), Family Office, Other Institutional Investors


E-mail: n.a.

Website: http://www.ietp.com

Phone number: +33 1 58 18 57 10

If you wish to have your details removed from this database please email gdpr@impactyield.com

Emilie Debled

Communication and Public Relations Director

Laetitia Latreille

Chief Financial Officer

Impact Performance


Impact thesis

IPDEV1 aims to develop an efficient private sector and strengthen the economic fabric in Africa through investments in SMEs and MFIs.
Investments target SMEs showing a strong impact in terms of (i) local added value (processing from local sourcing, development of the value chain, creation of local markets for smallholders), (ii) access to quality goods and services to local populations (iii)job creation.
IPDEV1’s impact outcomes include:
- creation and development of African SMEs: IPDEV has invested in 33 SGBs and MFIs which could not find other funding sources; 17 of them were start-ups co-founded by IPDEV.
- Job creation and poverty reduction: 1,400 jobs created and consolidated; indirect job created in the value chain especially with local suppliers. For example: 900 livestock farmers sell their milk to the dairy company Laiterie du Berger in the North of Senegal and 6,000 smallholder farmers supply Phileol, a castor oil producer in the South of Madagascar.
- Access to essential services: provision of financial services to 32,000 individuals, sustainable access to water and electricity for 10,000 individuals, access to affordable generic drugs and health services in Mali, Niger, Cameroon and Senegal.

Impact Management


Request information about this fund